DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression

Publication date: Available online 17 February 2021Source: Clinica Chimica ActaAuthor(s): Qiuxian Zheng, Xinyu Gu, Qin Yang, Qingfei Chu, Yiyang Dai, Zhi Chen

Source: Clinica Chimica Acta - February 17, 2021 Category: Laboratory Medicine Source Type: research